ContraVir Pharmaceuticals

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.

ContraVir Pharmaceuticals Inc. shares have been highly volatile of late, with the promise offered by its non-alcoholic steatohepatitis drug cushioning any downside for the stock.

ContraVir Rebounds From Record Low On Positive FDA Feedback

Shares of ContraVir Pharmaceuticals Inc. rocketed 69% in active premarket trading Friday.

ContraVir's stock rockets off record low after 'positive feedback' on pre-IND for NASH

ContraVir Pharmaceuticals Inc. shares were rallying Monday on positive news related to its non-alcoholic steatohepatitis, or NASH, drug.

ContraVir Moves Higher After NASH Drug Shows 100% Efficacy In Fibrosis Prevention

June has been an eventful month for ContraVir Pharmaceuticals Inc.

Why Low-Float, Thinly Traded ContraVir Pharma's Rally Is Continuing

Contravir Pharmaceuticals (CTRV) stock soared more than 12% on Friday as the company's treatment of liver disease is showing signs of promise.
The post Why ContraVir Pharmaceuticals (CTRV) Is Skyrocketing Today appeared first on InvestorPlace.

Why ContraVir Pharmaceuticals (CTRV) Is Skyrocketing Today

Shares of the nano-cap, thinly traded biotech ContraVir Pharmaceuticals Inc were trading nearly 150-percent higher Thursday.

News for ContraVir Pharmaceuticals Stock (CTRV)